Posted Sep. 16, 2011 at 12:41 p.m.

Premium Lock Cempra Pharmaceuticals touts anti-pneumonia drug

Published: 2011-09-16 12:41:43
Updated: 2011-09-16 12:41:43

Cempra Cempra

Dr. David Oldach, Cempra's senior vice president of clinical research, said in a statement that the company believes the data support progression of solithromycin into phase 3 trials. The full data will be presented at an upcoming scientific conference....

Read More
Read More

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders